GlassScriptPhysician profile
Catherine Johnson Cook
NPI 1639461833
$1,515.46
in general payments reported to CMS, 2019-2025
17 companies · $428 in 2025
The $428 reported for 2025 was more than what 83% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2023: $15.91 · 2024: $936 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $334.65 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Kowa Pharmaceuticals America, INC. | $286.73 | 2024-2025 | Zoryve |
| Abbott Laboratories | $146.71 | 2021-2024 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $138.61 | 2024 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.63 | 2024 | Xifaxan, Trulance |
| Nevro Corp. | $69.86 | 2024 | Senza |
| Eisai INC. | $69.27 | 2024-2025 | |
| Novo Nordisk INC | $63.27 | 2021-2025 | Wegovy |
| Glaxosmithkline, LLC. | $53.56 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Medtronic, INC. | $50.14 | 2024 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $47.17 | 2024 | Austedo Xr, Ajovy |
| Astellas Pharma US INC | $44.57 | 2024-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $38.96 | 2024 | Spravato |
| Pfizer INC. | $36.52 | 2024 | |
| Lilly USA, LLC | $18.26 | 2025 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.91 | 2023 | Trintellix |
| Exact Sciences Corporation | $13.64 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.